Skip to search formSkip to main contentSkip to account menu

Programmed cell death ligand 1 by clone SP142:Find:Pt:Tiss:Doc:Immune stain

Known as: PD-L1 by SP142 Tiss ImStn Doc, PD-L1 by clone SP142 in Tissue by Immune stain Report, Programmed cell death ligand 1 by clone SP142:Finding:Point in time:Tissue, unspecified:Document:Immune stain 
National Institutes of Health

Related topics

Related topics

7 relations
Body tissueDocumentsImmune stainOne

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2020
Review
2020
Atezolizumab Plus Nab-paclitaxel in PD-L1–Positive TNBC—Letter
Narayan and colleagues summarized the results and FDA's review leading to the accelerated approval of atezolizumab in combination… 
2019
2019
Concordance between PD-L1 assays for metastatic renal cell carcinoma (mRCC) and metastatic urothelial carcinoma (mUC).
e14259 Background: Immune checkpoint inhibitors (ICIs) are standard of care for mRCC and mUC patients (pts). PD-L1 status is… 
2017
2017
Concordance of tumor and immune cell staining with Ventana SP142, Ventana SP263, Dako 28-8 and Dako 22C3 PD-L1 tests in NSCLC patient samples.
e14503Background: PD-1/PD-L1 directed antibodies are emerging as effective oncology therapeutics with multiple diagnostic PD-L1… 
2017
2017
PD-L1-targeting drug atezolizumab nabs approval for non-small cell lung cancer
The approval last fall by the US Food and Drug Administration (FDA) of the immune checkpoint inhibitor atezolizumab for the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)